(VIANEWS) – First Citizens BancShares (FCNCA), Eton Pharmaceuticals (ETON), Eagle Point Credit Company (ECC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Citizens BancShares (FCNCA)
95.4% sales growth and 74.18% return on equity
First Citizens BancShares, Inc. operates as the holding company for First-Citizens Bank & Trust Company that provides retail and commercial banking services to individuals, businesses, and professionals. The company's deposit products include checking, savings, money market, and time deposit accounts. Its loan product portfolio comprises commercial construction and mortgage; and commercial and industrial leases, as well as small business administration paycheck protection program loans. In addition, the company offers consumer loans, such as residential and revolving mortgage, construction and land development, consumer auto, and other consumer loans. Further, it provides wealth management services, including annuities, discount brokerage services, and third-party mutual funds, as well as investment management and advisory services. The company provides its products and services through its branch network. First Citizens BancShares, Inc. was founded in 1898 and is headquartered in Raleigh, North Carolina.
Earnings Per Share
As for profitability, First Citizens BancShares has a trailing twelve months EPS of $766.86.
PE Ratio
First Citizens BancShares has a trailing twelve months price to earnings ratio of 1.86. Meaning, the purchaser of the share is investing $1.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.18%.
Yearly Top and Bottom Value
First Citizens BancShares’s stock is valued at $1,426.22 at 10:22 EST, under its 52-week high of $1,528.12 and way higher than its 52-week low of $505.84.
Revenue Growth
Year-on-year quarterly revenue growth grew by 105.6%, now sitting on 6.46B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 192% and 128.4%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 28, 2023, the estimated forward annual dividend rate is 6.56 and the estimated forward annual dividend yield is 0.46%.
2. Eton Pharmaceuticals (ETON)
56.5% sales growth and 15.9% return on equity
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Earnings Per Share
As for profitability, Eton Pharmaceuticals has a trailing twelve months EPS of $0.09.
PE Ratio
Eton Pharmaceuticals has a trailing twelve months price to earnings ratio of 48.67. Meaning, the purchaser of the share is investing $48.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Sales Growth
Eton Pharmaceuticals’s sales growth is negative 9.4% for the current quarter and 56.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 200% and positive 80% for the next.
Volume
Today’s last reported volume for Eton Pharmaceuticals is 128483 which is 44.04% above its average volume of 89198.
3. Eagle Point Credit Company (ECC)
23.6% sales growth and 16.22% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.09.
PE Ratio
Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 8.55. Meaning, the purchaser of the share is investing $8.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.22%.
Volume
Today’s last reported volume for Eagle Point Credit Company is 790196 which is 32.24% above its average volume of 597543.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 9, 2024, the estimated forward annual dividend rate is 1.68 and the estimated forward annual dividend yield is 17.85%.
Yearly Top and Bottom Value
Eagle Point Credit Company’s stock is valued at $9.32 at 10:22 EST, way below its 52-week high of $11.79 and above its 52-week low of $8.60.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 132.2M for the twelve trailing months.
4. Itau Unibanco (ITUB)
19.7% sales growth and 18.01% return on equity
Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies, as well as middle-market companies and high net worth clients. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. operates as a subsidiary of IUPAR – Itaú Unibanco Participações S.A.
Earnings Per Share
As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.68.
PE Ratio
Itau Unibanco has a trailing twelve months price to earnings ratio of 10.21. Meaning, the purchaser of the share is investing $10.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.01%.
Yearly Top and Bottom Value
Itau Unibanco’s stock is valued at $6.95 at 10:22 EST, above its 52-week high of $6.90.
Sales Growth
Itau Unibanco’s sales growth is 19.8% for the present quarter and 19.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 26.7% and 11.8%, respectively.
5. Terreno Realty Corporation (TRNO)
14.9% sales growth and 6.25% return on equity
Terreno Realty Corporation (“Terreno”, and together with its subsidiaries, “the Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. We invest in several types of industrial real estate, including warehouse/distribution (approximately 79.5% of our total annualized base rent as of December 31, 2021), flex (including light industrial and research and development, or R&D) (approximately 4.8%), transshipment (approximately 6.4%) and improved land (approximately 9.3%). We target functional properties in infill locations that may be shared by multiple tenants and that cater to customer demand within the various submarkets in which we operate. Infill locations are geographic locations surrounded by high concentrations of already developed land and existing buildings. As of December 31, 2021, we owned a total of 253 buildings aggregating approximately 15.1 million square feet, 36 improved land parcels consisting of approximately 127.1 acres and four properties under redevelopment that, upon completion, will consist of two properties aggregating approximately 0.2 million square feet and two improved land parcels aggregating approximately 12.1 acres. As of December 31, 2021, the buildings and improved land parcels were approximately 95.5% and 94.8% leased (including 0.4 million square feet of vacancy acquired during the fourth quarter of 2021), respectively, to 554 customers, the largest of which accounted for approximately 4.9% of our total annualized base rent.
Earnings Per Share
As for profitability, Terreno Realty Corporation has a trailing twelve months EPS of $1.9.
PE Ratio
Terreno Realty Corporation has a trailing twelve months price to earnings ratio of 33.29. Meaning, the purchaser of the share is investing $33.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.
Sales Growth
Terreno Realty Corporation’s sales growth is 10.8% for the present quarter and 14.9% for the next.
6. First Industrial Realty Trust (FR)
11.1% sales growth and 10.92% return on equity
First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers. Across major markets in the United States, our local market experts manage, lease, buy, (re)develop, and sell bulk and regional distribution centers, light industrial, and other industrial facility types. In total, we own and have under development approximately 64.1 million square feet of industrial space as of September 30, 2020.
Earnings Per Share
As for profitability, First Industrial Realty Trust has a trailing twelve months EPS of $2.02.
PE Ratio
First Industrial Realty Trust has a trailing twelve months price to earnings ratio of 26.22. Meaning, the purchaser of the share is investing $26.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.92%.
7. InMode Ltd. (INMD)
10.3% sales growth and 29.3% return on equity
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.
Earnings Per Share
As for profitability, InMode Ltd. has a trailing twelve months EPS of $2.1.
PE Ratio
InMode Ltd. has a trailing twelve months price to earnings ratio of 11. Meaning, the purchaser of the share is investing $11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.3%.
Yearly Top and Bottom Value
InMode Ltd. ‘s stock is valued at $23.09 at 10:22 EST, way below its 52-week high of $48.25 and way above its 52-week low of $18.57.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 15.4% and positive 1.9% for the next.
Sales Growth
InMode Ltd. ‘s sales growth is negative 0.7% for the current quarter and 10.3% for the next.
8. Visteon Corporation (VC)
6.3% sales growth and 23.03% return on equity
Visteon Corporation engineers, designs, and manufactures cockpit electronics and connected car solutions for vehicle manufacturers worldwide. The company provides instrument clusters, including standard analog gauge clusters to high-resolution, all-digital, fully reconfigurable, 2-D, and 3-D display-based devices; information displays that integrate a range of user interface technologies and graphics management capabilities; and audio and infotainment systems that allows vehicle occupants to connect their mobile devices to the system and safely access phone functions, listen to music, stream media, and enable mobile connectivity applications. It also offers infotainment solutions, including Phoenix display audio and embedded infotainment platform; telematics control unit to enable secure connected car services, software updates, and data; SmartCore, an automotive-grade, integrated domain controller to enhance efficiency, and reduce power consumption and cost; and head-up displays (HUD), such as combiner HUD and windshield HUD that present critical information to the driver. Visteon Corporation was founded in 2000 and is headquartered in Van Buren, Michigan.
Earnings Per Share
As for profitability, Visteon Corporation has a trailing twelve months EPS of $5.39.
PE Ratio
Visteon Corporation has a trailing twelve months price to earnings ratio of 23.75. Meaning, the purchaser of the share is investing $23.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.03%.
Moving Average
Visteon Corporation’s value is higher than its 50-day moving average of $122.21 and under its 200-day moving average of $139.41.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Visteon Corporation’s EBITDA is 0.87.
Volume
Today’s last reported volume for Visteon Corporation is 864906 which is 172.19% above its average volume of 317753.
